View clinical trials related to Diastolic Heart Failure.
Filter by:We hypothesize that nesiritide will have favorable effect in decreasing heart filling pressures and echocardiogram studies.
The aim of this study was to determine whether long-term (≥ 6 months at the target dose) blockade of ETA receptors using sitaxsentan showed functional benefit in subjects with chronic Heart Failure and an Left Ventricular Ejection Fraction ≥50%.
The purpose of this study is to examine whether spironolactone will improve exercise tolerance and quality of life in elderly patients with heart failure preserved ejection fraction (HFPEF).